Tanja KrainzHead of Strategy & Business Development at NovoArc GmbHPresenter
Profile
Dr. Tanja Krainz is Head of Strategy & Business Development at NovoArc GmbH, where she drives strategic partnerships, commercial and fundraising activities for the company's extra-hepatic RNA delivery and in-vivo cell engineering platform. With a PhD in organic chemistry and a background in medicinal chemistry, drug discovery and venture creation, she has contributed to numerous scientific publications, patents, and therapeutic development programs. Combining deep scientific expertise with business development experience, Dr. Krainz focuses on building collaborations that advance innovative drug discovery and delivery technologies and accelerate the translation of cutting edge research into therapeutic solutions.
